Increased expression of regulatory tr1 cells in recurrent hepatitis C after liver transplantation

American Journal of Transplantation

Volumn 9, Issue 9, 2009, Pages 2102-2112

  Carpentier, A ^a,b   Conti, F ^a,c   Stenard, F ^a,c   Aoudjehane, L ^a   Miroux, C ^b   Podevin, P ^a   Morales, O ^b   Chouzenoux, S ^a   Scatton, O ^c   Groux, H ^d   Auriault, C ^d   Calmus, Y ^a,c   Pancre, V ^b   Delhem, N ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

^c Hôpital Cochin ^*  (France)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Hepatitis C; Liver transplantation; Regulatory T cells; Tr1

Indexed keywords

ALPHA2 INTEGRIN; CD18 ANTIGEN; CD4 ANTIGEN; CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PREDNISOLONE; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; TRANSCRIPTOMICS;

ADULT; ANTIGENS, CD18; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS C; HUMANS; INTEGRIN ALPHA2; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; T-LYMPHOCYTES, REGULATORY;

EID: 69149083247     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02743.x     Document Type: Article

References (40)

1. Curry MP. Hepatitis B and hepatitis C viruses in liver transplantation. Transplantation 2004 78 : 955 963.
2. Velidedeoglu E, Mange KC, Frank A et al. Factors differentially correlated with the outcome of liver transplantation on HCV+ and HCV- recipients. Transplantation 2004 77 : 1834 1842.
3. Berenguer M, Prieto M, San Juan F et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002 36 : 202 210. Erratum in Hepatology 2003 37 : 489.
4. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 : 1395 1406.
5. Gerlach JT, Diepolder HM, Jung MC et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999 117 : 933 941.
6. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity. Hepatology 1997 25 : 449 458.
7. Murata M, Nabeshima S, Maeda N, Nakashima H, Kashiwagi S, Hayashi J. Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C. J Med Virol 2002 67 : 162 170.
8. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004 10 : 801 805.
9. Sakaguchi S, Sakagushi N, Shimizu J et al. Immunologic tolerance maintained by CD4+CD25+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity and transplantation tolerance. Immunol Rev 2001 182 : 18 32.
10. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J Immunol 1995 155 : 1151 1164.
11. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakagushi S. Stimulation of CD25+CD4 +regulatory T cells through GITR breaks immunological self-tolerance Nat Immunol 2002 3 : 135 142.
12. Birebent B, Lorho R, Lechartier H et al. Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression Eur J Immunol 2004 34 : 3485 3496.
13. Hori S, Nomura T, Sakagushi S. Control of regulatory T cells development by the transcription factor FoxP3 Science 2003 299 : 1057 1061.
14. Morgan ME, van Bilsen JHM, Bakker AM et al. Expression of Fox P3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans Hum Immunol 2005 66 : 13 20.
15. Groux H, O'Garra A, Bigler M et al. A CD4 +T-cell subset inhibits antigen-specific T-cell responses and prevent colitis Nature 1997 389 : 737 742.
16. Rahmoun M, Foussat A, Groux H, Pene J, Yssel H, Chanez P. Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity. Int Arch Allergy Immunol 2006 140 : 139 149.
17. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001 182 : 207 214.
18. Cabrera R, Tu Z, Xu Y et al. An immunomodulatory role for CD4 (+) CD25 (+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004 40 : 1062 1071.
19. Rushbrook SM, Ward SM, Unitt E et al. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 2005 79 : 7852 7859.
20. Boettler T, Spangenberg HC, Neumann-Haefelin C et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005 79 : 7860 7867.
21. Manigold T, Shin EC, Mizukoshi E et al. Foxp3+CD4+CD25 +T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 2006 107 : 4424 4432.
22. Delpuech O, Buffello-Le Guillou DB, Rubinstein E, Feray C, Petit MA. The hepatitis C virus (HCV) induces a long-term increase in interleukin-10 production by human CD4+ T cells (H9). Eur Cytokine Netw 2001 12 : 69 77.
23. MacDonald AJ, Duffy M, Brady MT, McKiernan S, Hall W, Hegarty J et al. CD4 T helper type 1 regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons J Infect Dis 2002 185 : 720 727.
24. Brady MT, MacDonald AJ, Rowan AG, Mills KH. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 2003 33 : 3448 3457.
25. Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000 118 : 346 355.
26. + regulatory T cells. Transpl Immunol 2008 19 : 127 135.
27. Joffre O, Santolaria T, Calise D et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3 +regulatory T lymphocytes. Nat Med 2008 14 : 88 92.
28. Zeiser R, Nguyen VH, Beilhack A et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 2006 108 : 390 399.
29. Demirkiran A, Kok A, Kwekkeboom J et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transplant 2006 12 : 277 284.
30. Stenard F, Nguyen C, Cox K et al. Decreases in circulating CD4(+)CD25(hi)FOXP3(+) cells and increases in intragraft FOXP3(+) cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 2009 13 : 70 80.
31. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology 1996 24 : 289 293.
32. Carpentier A, Conti F, Carrière M et al. Analysis of gene transcription in sera during chronic hepatitis C infection. J Med Virol 2009 473 480.
33. -ΔΔCT method. Methods 2001 25 : 402 408.
34. Burton JR and Rosen HR. Acute rejection in HCV-infected liver transplant recipients: The great conundrum. Liver Transpl 2006 12 : S38 S47.
35. Walter T, Dumortier J, Guillaud O, Hervieu B, Paillard,Scoazec JY, Boillot O. Rejection under alpha interferon therapy in livertransplant recipients. Am J Transplant 2007 7 : 177 171.
36. Demirkiran A, Kok A, Kwekkeboom J, Metselaar HJ, Tilanus HW, Van Der Laan LJ. Decrease of CD4(+)CD25(+) T cells in peripheral blood after liver transplantation: Association with immunosuppression. Transplant Proc 2005 37 : 1194 1196.
37. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J Exp Med 2002 196 : 851 857.
38. Roncarolo MG, Bachetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001 182 : 68 79.
39. Conti F, Frappier J, Dharancy S et al. Interleukin-15 production during liver allograft rejection in humans. Transplantation 2003 76 : 210 216.
40. Kakumu S, Okumura A, Ishikawa T et al. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF alpha) receptors in type C chronic liver disease. Clin Exp Immunol 1997 109 : 458 463.